SCHEMBL30406941

SCHEMBL30406941

CC1(CNc2ncc3c(-c4ccc5ncccc5c4)c[nH]c3n2)CC1

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ DYRK1A Q13627 9/20 0.55
▸ CLK2 P49760 2/20 0.55
▸ CLK3 P49761 2/20 0.55
▸ CLK1 P49759 1/20 0.49
▸ CLK4 Q9HAZ1 1/20 0.49
▸ BRD4 O60885 2/20 0.42
▸ DYRK1B Q9Y463 2/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ SSTR3 P32745 1/20 0.37
▸ TLR8 Q9NR97 1/20 0.37
▸ TLR7 Q9NYK1 1/20 0.37
▸ AR P10275 1/20 0.37
▸ ADORA1 P30542 1/20 0.36
▸ PDGFRB P09619 1/20 0.35
▸ PDGFRA P16234 1/20 0.35
▸ ADORA2A P29274 1/20 0.35
▸ TDO2 P48775 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25157448 1.00 DYRK1A (0.55) DYRK1ACLK2CLK3CLK1CLK4
SCHEMBL25157291 0.89 DYRK1A (0.43) DYRK1ACLK2CLK3CLK1CLK4
SCHEMBL30347095 0.89 DYRK1A (0.43) DYRK1ACLK2CLK3CLK1CLK4
SCHEMBL30407028 0.88 DYRK1A (0.53) DYRK1ACLK2CLK3CLK1CLK4
SCHEMBL25212368 0.88 DYRK1A (0.53) DYRK1ACLK2CLK3CLK1CLK4
SCHEMBL25157725 0.87 DYRK1A (0.51) DYRK1ACLK2CLK3CLK1CLK4
SCHEMBL30348766 0.87 DYRK1A (0.51) DYRK1ACLK2CLK3CLK1CLK4
SCHEMBL25211921 0.86 TDO2 (0.49) DYRK1ACLK2CLK3CLK1CLK4
SCHEMBL25157722 0.86 DYRK1A (0.51) DYRK1ACLK2CLK3CLK1CLK4
SCHEMBL25196709 0.86 DYRK1A (0.51) DYRK1ACLK2CLK3CLK1CLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250129104-A1 7H-PYRROLO[2,3-D]PYRIMIDINES AND PREPARATION AND USES THEREOF TENARX, INC. 2025-04-24 — — US claimed
US-20230167133-A1 7H-PYRROLO[2,3-D]PYRIMIDINES AND PREPARATION AND USES THEREOF VICKERS VENTURE FUND VI PTE. LTD. (SG) 2023-06-01 — — US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167133-A1 7H-PYRROLO[2,3-D]PYRIMIDINES AND PREPARATION AND USES THEREOF DYRK1A, DYRK1B, DYRK2 DYRK1A 1/4885CLK2 466/4885CLK3 1147/4885
US-20250129104-A1 7H-PYRROLO[2,3-D]PYRIMIDINES AND PREPARATION AND USES THEREOF DYRK1A, DYRK1B, DYRK2 DYRK1A 1/4885CLK2 466/4885CLK3 1147/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback